← Browse by Condition
Medical Condition

colorectal cancer

Total Trials
77
Recruiting Now
77
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT05710809
Recruiting

The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer

Enrollment
150 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
View Trial →
NCT05787587 Phase 1
Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
View Trial →
NCT07071714 Phase 2
Recruiting

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

Enrollment
200 pts
Location
China
Sponsor
Suzhou Suncadia Biopharmaceuti...
View Trial →
NCT05993923
Recruiting

Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer

Enrollment
90 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT05771181 Phase 2
Recruiting

Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients

Enrollment
25 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT06640166 Phase 2
Recruiting

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT05961969
Recruiting

Robotic Top-down Intersphincteric Resection

Enrollment
40 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT05813028
Recruiting

The Effect of a Mobile Application on Patient Outcomes in Colorectal Cancer Patients

Enrollment
100 pts
Location
Turkey (Türkiye)
Sponsor
Ankara University
View Trial →
NCT02070146
Recruiting

Prospective Data Collection Initiative on Colorectal Cancer

Enrollment
50,000 pts
Location
Netherlands
Sponsor
Dutch Colorectal Cancer Group
View Trial →
NCT06349590 Phase 1, Phase 2
Recruiting

Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery

Enrollment
80 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT06168786 Phase 2
Recruiting

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Enrollment
40 pts
Location
China
Sponsor
Huazhong University of Science...
View Trial →
NCT06780423
Recruiting

Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients

Enrollment
60 pts
Location
Belgium
Sponsor
Hasselt University
View Trial →
NCT03965234 Phase 1, Phase 2
Recruiting

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Enrollment
99 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
View Trial →
NCT06783244
Recruiting

Low Versus Standard Intraabdominal Pressure in Robot-assisted Colorectal Cancer Surgery

Enrollment
200 pts
Location
Denmark
Sponsor
Victoria Rosberg
View Trial →
NCT05346757
Recruiting

Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis

Enrollment
5,390 pts
Location
Spain
Sponsor
Fundacion Clinic per a la Rece...
View Trial →
NCT05195970
Recruiting

Walnuts and Colon Health

Enrollment
200 pts
Location
United States
Sponsor
UConn Health
View Trial →
NCT06047379 Phase 1, Phase 2
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
View Trial →
NCT06452745
Recruiting

Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile

Enrollment
2,000 pts
Location
Spain
Sponsor
Institut Investigacio Sanitari...
View Trial →
NCT06973161
Recruiting

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

Enrollment
105 pts
Location
United States, Austr...
Sponsor
AstraZeneca
View Trial →
NCT05168839 Phase 3
Recruiting

Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage

Enrollment
1,010 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06395519 Phase 1, Phase 2
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
View Trial →
NCT06413212
Recruiting

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Enrollment
55 pts
Location
China
Sponsor
Liu Huang
View Trial →
NCT07216105 Phase 1
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Enrollment
113 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT03957902 Phase 2
Recruiting

Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer

Enrollment
60 pts
Location
Spain
Sponsor
Instituto de Investigación San...
View Trial →
NCT05676190
Recruiting

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

Enrollment
80 pts
Location
China
Sponsor
ShiCang Yu
View Trial →
NCT05224518
Recruiting

Exercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer

Enrollment
106 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT07371273 Phase 2
Recruiting

Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR

Enrollment
100 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT05343013 Phase 2
Recruiting

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Enrollment
25 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06819215 Phase 1, Phase 2
Recruiting

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Enrollment
188 pts
Location
China
Sponsor
Zhejiang Yangli Pharmaceutical...
View Trial →
NCT06251297
Recruiting

Feasibility and Benefits of Reflexology in the Prevention of Neuropathy Induced by Oxaliplatin in Colorectal Cancer

Enrollment
40 pts
Location
France
Sponsor
University Hospital, Toulouse
View Trial →
NCT06326879
Recruiting

A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients

Enrollment
340 pts
Location
Italy
Sponsor
Istituto Clinico Humanitas
View Trial →
NCT06501482 Phase 3
Recruiting

Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI

Enrollment
254 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06440005 Phase 1
Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
View Trial →
NCT07261631 Phase 1
Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Enrollment
180 pts
Location
Canada, France, Isra...
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07136077 Phase 2
Recruiting

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Enrollment
20 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06220617
Recruiting

Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)

Enrollment
3,600 pts
Location
China
Sponsor
Zhejiang University
View Trial →
NCT05571644 Phase 2
Recruiting

Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer

Enrollment
143 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →
NCT07327489
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
View Trial →
NCT06098560
Recruiting

Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients

Enrollment
60 pts
Location
China
Sponsor
Geneplus-Beijing Co. Ltd.
View Trial →
NCT05495776
Recruiting

Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer

Enrollment
2,500 pts
Location
Russia
Sponsor
State Scientific Centre of Col...
View Trial →
NCT06259149
Recruiting

A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery

Enrollment
914 pts
Location
China
Sponsor
RenJi Hospital
View Trial →
NCT03787056
Recruiting

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT06580002 Phase 2
Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Enrollment
51 pts
Location
United States
Sponsor
University of California, Irvi...
View Trial →
NCT07227636 Phase 2
Recruiting

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Enrollment
284 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT05861505 Phase 3
Recruiting

COLLISION RELAPSE Trial

Enrollment
360 pts
Location
Netherlands
Sponsor
Amsterdam UMC, location VUmc
View Trial →
NCT06456229
Recruiting

Time to Return of Bowel Function Following Perioperative Probiotics in Colorectal Cancer Surgery

Enrollment
162 pts
Location
Singapore
Sponsor
National University Hospital, ...
View Trial →
NCT05517811
Recruiting

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Enrollment
400 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04282044 Phase 1
Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
View Trial →
NCT07189312
Recruiting

Multi-scale Spatio-Temporal Analysis of Research Data

Enrollment
15 pts
Location
Spain
Sponsor
Universidad de Granada
View Trial →
NCT07202364 Phase 2
Recruiting

A Study of YL202 in Patients With Advanced Solid Tumors

Enrollment
100 pts
Location
China
Sponsor
MediLink Therapeutics (Suzhou)...
View Trial →
NCT05319314 Phase 1
Recruiting

GCC19CART for Patients With Metastatic Colorectal Cancer

Enrollment
30 pts
Location
United States
Sponsor
Lyell Immunopharma, Inc.
View Trial →
NCT05880992
Recruiting

Trimodal Prehabilitation in Colorectal Cancer Patients

Enrollment
50 pts
Location
Canada
Sponsor
Jordan Leitch
View Trial →
NCT05286814 Phase 2
Recruiting

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT04429542 Phase 1
Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics
View Trial →
NCT06409403
Recruiting

Study on Effect of Robotic Versus Laparoscopic Surgical Technology on Genitourinary Function After Total Mesorectal Excision for Rectal Cancer

Enrollment
164 pts
Location
China
Sponsor
general surgery 3
View Trial →
NCT07105631
Recruiting

Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World

Enrollment
300 pts
Location
China
Sponsor
West China Hospital
View Trial →
NCT02328677
Recruiting

ColoCare Study - Colorectal Cancer Cohort

Enrollment
5,000 pts
Location
United States, Germa...
Sponsor
University of Utah
View Trial →
NCT06342401
Recruiting

Early Onset Colorectal Cancer Detection

Enrollment
400 pts
Location
United States, Italy...
Sponsor
City of Hope Medical Center
View Trial →
NCT06356584 Phase 2
Recruiting

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Enrollment
62 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
View Trial →
NCT07152821 Phase 3
Recruiting

Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma

Enrollment
834 pts
Location
Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06287814
Recruiting

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

Enrollment
70 pts
Location
France
Sponsor
University Hospital, Montpelli...
View Trial →
NCT06586515 Phase 1
Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Enrollment
630 pts
Location
United States, Canad...
Sponsor
Eli Lilly and Company
View Trial →
NCT04120935
Recruiting

ALFAOMEGA Master Observational Trial

Enrollment
3,000 pts
Location
Italy, Spain
Sponsor
IFOM ETS - The AIRC Institute ...
View Trial →
NCT04585750 Phase 1, Phase 2
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc
View Trial →
NCT04767568
Recruiting

Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening

Enrollment
400 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07310446
Recruiting

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

Enrollment
6,500 pts
Location
United States
Sponsor
Universal Diagnostics
View Trial →
NCT05576896 Phase 2
Recruiting

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Enrollment
43 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT06445062 Phase 1, Phase 2
Recruiting

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT06281678 Phase 2
Recruiting

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Enrollment
178 pts
Location
United States
Sponsor
Innovent Biologics (Suzhou) Co...
View Trial →
NCT07321106 Phase 1
Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Enrollment
80 pts
Location
United States
Sponsor
Cartography Biosciences
View Trial →
NCT06903325
Recruiting

A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases

Enrollment
50 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT06649123
Recruiting

Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer

Enrollment
6,600 pts
Location
United Kingdom
Sponsor
Origin Sciences
View Trial →
NCT05102110
Recruiting

Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

Enrollment
450 pts
Location
United Kingdom
Sponsor
Origin Sciences
View Trial →
NCT07042243
Recruiting

The Florida ASCENT Study

Enrollment
100 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05044689
Recruiting

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Enrollment
800 pts
Location
Nigeria
Sponsor
Obafemi Awolowo University Tea...
View Trial →
NCT06307249 Phase 1
Recruiting

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Enrollment
50 pts
Location
Lebanon
Sponsor
Lebanese University
View Trial →
NCT05005117
Recruiting

Laparoscopic Approach for Emergency Colon Resection

Enrollment
192 pts
Location
Finland
Sponsor
Joint Authority for Päijät-Häm...
View Trial →